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CHAPTER 5 IMMUNODEFICIEN CY 
DISEASES 
AND TUMOR 
IMMUNOBIOLOGY 
RENE J. DUQ.UESNOY 
PETER ABRAMOFF 
INTRODUCTION 
Basic progress toward an improved under-
standing of the relation of structure to function of 
cella, tiaauee, and organs of the lymphoid sys~m 
has taught us about the significance of the Im-
mune apparatus in the pathogenesis of many 
di8ea8e procesaes. The classic definition of immu-
nity u being an exemption from disease has 
traditionally been related to resistance to infec-
tion. Until the turn of the century, the immune 
ayttem wu considered to have evolved as a ho-
meoetatic mechanism specifically directed 
qainat. infectious agents. It is now recognized 
that the immune system participates in many 
proceuee of tiuue ~ury elicited by hypersensi-
tivity reactions against a great variety of innocu-
oua sut.tancea. These immunologicalJy medi-
ated hypenenaitivity reactions of tissue injury 
are divided into four major categories: (1) The im-
mediate-type of hypersensitivity reactions me-
diated by the humoral immune system. (2) The 
delayed-type of hypersensitivity reactions which 
are manifestations of cellular immunity. (3) The 
immune ClOIIlplex diaeasea which result from the 
depoaitioa ol circulating aoluble antigen-an-
tibody complexes in the walla of blood vessels and 
the glomeruli (4) Autoallergic disorders which 
may oocur u a consequence of immunologic reac-
tivity again8t the host's own tissue components. 
Theae hypeneoaitivity reactions will be dis-
CUlled in greater length in Chapters 17 and 18. 
This chapter deala with the immunopathologic 
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mechanisms which underlie certain normali· 
ties of the lymphoid system. We will d • uss those 
primary immunodeficiency disorde~~ due to; 
developmental defect of.the lymphOI~ . ... ystem to 
well as the immunodeficiency sta tes St ~ondary 
various diseases. lfunc· 
In the section on tumor immunolog~ ma ' lh 
tion of immunologic processes in patl~nts WI f 
malignant disease will be analyzed 1 terms 0 
the surveillance function of the lymplund system 
of maJignant growth. 
IMMUNODEFICIENCY DISEASES 
Development of the Lymphoid System 
The hematopoietic system develop:-; from h~.m~ 
topoietic stem cells residing at diffe rent l o~a ·~he 
during ontogenesis; these locations a re 10 (i tal 
primitive blood islets of the yolk sac, the ~e.lll 
liver and finally in the bone marrow These 5 the 
cells 'can proliferate and diffe rentiate ~lon~on~ 
hematopoie tic pathways of th e e'?-thrOid, boid 
cytic, granulocytic, megakaryocytic. or lymP 
systems. . d stem 
In the lymphoid system, the lympho• hocyte 
cells may differentiate to form two lymp d"' h' h are ~· populations: the T lymphocytes, w 1~ 
1 
rnpbo-
pendent upon the thymus, and the ~efined 
cytes, which are dependent upon an u.n fluentt 
bursa equivalent (Fig. 5-l). U nder the 10 f the 
of the inductive microenviron ments 0 
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THYMUS SYSTEM DEVELOPMENT 
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BURSAL SYSTEM DEVELOPMENT 
..... 1-1 Two-component concept of the lymphoid system. Lymphoid stem cells may proliferate and differ-
11111111 under Influences of the thymus or a bursa equivalent to give rise to populations ofT and 8 lymphocytes. 
IIIPICihety. (Courtesy of Dr. Robert A. Good, Director of Sloan-Kettering Institute, New York.) 
.,_.cortex and medulla, the prethymic lym-
... ltem cells proliferate and differentiate into 
'r ~ (T cells). The lymphocytes which 
lllide iD the thymus and which have di fferent 
.... ~lymphoid development are called thy-
~ It ia not certain whether differentiation 
~into aT cell takes place within the 
ti-...... before emigration or in the peripheral 
- Recent exper iments with mice indicate 
.... .-tam medullary thymocytes have proper-
lbailar to peripheral T lymphocytes. Fur-:;;i&~ that subpopulations of T lympho-
:S , ~ ~~lo;~~nt~ l~e:;:~. ~~~e i;: 
---· l•'llcll! function. 
.. U::::ogenic stimulation , certain T cells 
... , ll!llll.;--~ and differentiate to become sensi-
..... eeUe. These sensitized T cells can be ac-
,._ bJ antigen to become "killer" lympho-
11bicb produce soluble factors called 
and give rise to the so-called ampli-
lflt,em of cellular immunity. T cells have 
ta ~ to interact synergistically with ~ the unmune response of mice and a 
... ,~of other species, bu~ not in rna~. 
-....... v....,bocyt.es may express ImmunologiC 
·~
1!111iif fl I are found in the deep cortical lliiiiatt ~ph nodes, the periarteriolar 
lllleniC foUicles, the diffused lymphoid 
tissue of the gastrointestinal tract, the thoracic 
duel Jymph, and the circulating blood. 
ln the chicken, the organ respons ible for the 
differentiation of lymphoid stem cells into B lym-
phocytes (B cells) is the bursa of Fabricius. It has 
yet to be identified in the mammalian species. 
The appendix, Peyer's patches, and gut-as-
sociated lymphoid tissue as well as tonsils, bone 
marrow, and even skin have been implica ted as 
the mammalian bursa equivalent; however, these 
postulates lack sufficient experimental evidence. 
There are two categories of B cells: the non-
secreting and the secreting B cells. B cells of the 
first group are capable of synth esizing antibody 
but a re not specialized for antibody secretion in 
large amounts. These cells carry immunoglobulin 
receptors for both light. and heavy chains and, in 
mice, also have receptors for C3. They can be 
found in the far cortical areas of lymph nodes, the 
perifoiJicular zones of the malpighiao corpuscles 
of the spleen, and the circulating blood. 
Upon interaction with antigen , nonsecretiog B 
cells can transform into secreting B lymphocytes 
or plasma cells. These cells are specialized for 
production and secretion of antibody. They can be 
found in the medullary cords of lymph nodes, in 
the red pulp of the spleen , in the lamina propria 
of the gastrointestinal tract and secretory glands, 
in the interstitial tissue of the bone marrow, and, 
occasionally, in the peripheral blood and lymph. 
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The two-component concept of the lymphoid 
system implies that there are two basic syn-
dromes of immunodeficiency: one, a deficiency of 
humoral immunity as a consequence of an abnor-
mality of the B cell system, and the other, a defect 
of the T cell system of cellular immunity. Pa-
tients with immunodeficiency diseases manifest 
parts of each syndrome, depending upon the type 
and extent of their deficiency. Careful diagnostic 
evaluation of both BandT cell systems is manda-
tory in the proper management and treatment of 
the disease in these patients. 
Evaluation of the T Cell System 
Generally , a T cell deficiency is indicated with 
increased susceptibili ty to infection by fungi, 
viruses, atypical acid-fast organisms, and some of 
the so-called lower-grade pathogens. Causative 
organisms include Candida albicans, vaccinia 
and mumps viruses, Mycoplasma, Staphylo-
coccus, and Pneumocystis carinii. On the other 
hand, fewer problems are encountered with high-
grade encapsulated pathogens, such as Pneumo-
coccus, Haemophilus, Streptococcus, and Men-
ingococcus. 
Pneumocystis carinii deserves special atten-
tion, since it frequently causes severe pulmonary 
disease in patients with immunodeficiency. In 
these patients, pneumocystis pneumonia shows 
characteristic accumulations of foamy, pink-
staining exudates containing many pneumocystis 
organisms (Fig. 5-2A and B). This protozoan 
produces disease in patients with B a nd T cell 
deficiencies and has also caused plasma cell pneu-
monia epidemics in neonates and premature and 
debilitated infants in central Europe. The diag-
nosis of pneumocystis infections in patients with 
immunodeficiency disease is hampered by the ab-
sence of any demonstrable specific immune re-
sponse. Demonstration of specific antibodies in 
close relatives of the patient may provide an in-
dication of pneumocystis infection; otherwise, a 
lung biopsy is a better diagnostic measurement. 
Early pneumocystis infection can be effectively 
treated with pentamidine isethionate. 
The laboratory evaluation of the T cell system 
in patients with suspected immunodeficiency is 
given in Table 5-1. An effective test for the anal-
ysis of the T cell population is a quantitation of 
the responsiveness of peripheral blood lympho-
cytes or lymph node cells to blastogenic stimula-
tion with phytohemagglutinin (PHA). The capa-
bility to develop delayed allergic reactions may 
be analyzed by the ability to develop contact 
allergy after stimulation with dinitrochloroben-
zene (DNCB). Skin tests for delayed hypersensi-
tivity to ubiquitous antigens such as mumps, 
Candida, Trichophyton, tu'berculin, histoplasmin, 
and streptokinase-streptodornase may be of little 
value in young children who have had little op-
portunity to develop cell-mediated i m rnune re-
sponses to these antigens. However . negative 
skin tests to Candida antigens in chiltl ·n suffer· 
ing from infection with this fungus -~ay have 
diagnostic usefulness. Tests for the .tbility ro 
reject allogeneic skin grafts are no l o; ,~er com-
monly used. 
Morphologic analysis of the numbe of small 
lymphocytes in peripheral blood and i the deep 
cortical areas of biopsied lymph node~ nay pro-
vide some quantitation of the TcelJ sys r m. Since 
T lymphocytes do not have immunog1{,bulin re-
ceptors on their cell su1'face, mem ·• a ne im· 
munofluorescence methods with fiuor :.cent Ia· 
beled antiglobulin antibodies shoulJ give 8 
higher ratio of positively staining lymJ •ocytes in 
T cell deficient patients than in norm u persons. 
Although T cells in mice have specific lllembrane 
markers (e.g., theta and TL antig· ts}, such 
markers have not been demonstrated (1 0 human 
T cells. 
Several tests for lymphokine prod u~· ion have 
been developed which are of potential usefulness 
in the evaluation of the amplification :.;ystem of 
cellular immunity. In particular, tht: ca pillary 
test for migration inhibitory factor h ab become 8 
routine procedure in many laboratorie". 
Evaluation of the 8 Cell System 
A deficiency of the B cell system is ge uerally in· 
dicated with frequent occurrences of infection 
causing pneumonia, otitis media, conJunctivitis, 
meningitis, and sepsis. Causative microorga· 
nisms incJude Pneumococcus, Streptococcus, 
Haemophilus, Meningococcus, Pscudorno~ 
aerugirwsa, hepatitis virus, and P neumocysiJS 
carinii. These patients experience fewe r problems 
with handling of Staphylococcus, most enterobac· 
teria, mycobacteria, fungi, and viruses. 
Most laboratory tests for evaluation of the B 
cell system are carried out on the products o~ B 
lymphocytes, i.e., the antibodies and un· 
munoglobulins (Table 5-2). Electrophoretic an~ 
immunoelectrophoretic analyses of serum an 
secretions provide qualitative informa t ion a~ut 
the presence or absence of the various 1Jll' 
munoglobulins, as well as the prese nce of b~ 
mogeneous immunoglobulin populations seen 10 
monoclonal gammopathies. 
A variety of immunologic methods are c~r· 
rently available for determining immunoglob~ 
levels. Most commonly used is the radial iJII· 
munoditfusion technique by which the test~ 
is allowed to diffuse in a layer of agar gel contaJll' 
ing antiserum specific to one of the j []llJl~ 
globulins. The concentration of each irnm~OO' 
globulin is determined by comparing th~ di~ 
eter of the precipitin ring with that gtven J 
an immunoglobulin standard solution of delin 
concentration. When special precautions are 
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• • 
--· . ~~ Pneumocystis pneumonia in an agammaglobulinemic patient. A, Eosinophilic accumulations in 
...._,Of ~on. B, Pneumocystis carlnii organisms in pulmonary exudate. (Courtesy of Dr. Robert A. Good, 
oan-Ketterlng Institute, New York.) 
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TABLE 5-1 LABORATORY EVALUATION OF 
T CELL FUNCTION 
1. Microbiological studies, history of infections. 
2. Quantitation of PHA-ioduced lymphocyte 
blastogenesis. 
3. Skin t.est.s for delayed hypersensitivity to ubiquitous 
antigens. 
4. Development of contact a llergy to DNCB. 
5. Blood lymphocyte count. 
6. Allogeneic skin graft rejection. 
7. Histologic analysis of lymphocyte populations in 
thymus-dependent areas of lymph nodes. 
8. Immunoglobulin receptors on lymphocytes. 
9. Amplification of cellular immunity, MJF test. 
taken to ensure that the immunoglobulins in the 
standards and the sera are not split or ag-
gregated, the radial immunodiffusion method can 
be used to measure, with some accw·acy, the 
levels of IgG, IgM, lgA, and JgD. Serum lgE 
levels are measured with the radioimmunoassay 
method. The normal values for each of these im-
munoglobulins are given on p. 101. Caution 
should be given in the evaluation of im-
munoglobulin levels in adult serum, s ince they 
may vary greatly from individual to individual 
and a re related to age, sex, environment, and 
racial background. No threshold for values can be 
set for the diagnosis of immunoglobulin deficien-
cies unless associated with clinical symptoms. 
Rel iable measurements cannot be made with 
such proteins as low molecular weight IgM and 
secretory IgA unless a standard immunoglobulin 
is available in the same form. 
Special attention should be given to analysis of 
the subclasses of immunoglobulins. Using appro-
priate antisera, the levels of immunoglobulin 
subclasses are measured by radial immunodif-
fusion or direct hemagglutination-inhibition 
tests. The approximate percentages in American 
Caucasians of norma] serum lgG are lgG1, 66 per 
cent; l gG2 , 23 per cent; IgGa, 7 per cent; and IgG~, 
4 per cent. The importance of determining im-
munoglobulin subclasses has been demonstrated 
in certain patients with normal total IgG serum 
levels, but lacking one of the IgG subclasses, and 
showing great susceptibility to pneumococcaJ and 
other high-grade, extracellular, pyogenic path-
ogens, similar to patients with generalized B cell 
immunodeficiency diseases. 
Humoral immune function of the B ceU system 
can be evaluated by tests for existing antibody to 
antigen to which man is commonly exposed or by 
humoral antibody assays following active im-
munization. Antibodies to ubiquitous antigens 
include type A and B isohemagglutinins and an-
tibodies to infectious agents, e.g., antistrep-
tolysin 0 , antiviral antibodies and agglutinins 
of typhoid, paratyphoid, brucella, diphtheria, 
tetanus, Candida, and Staphylocc 
antigens used for active immunizati 
be proteins as well as polysaccharide:-. 
tion of antibody responses may be • 
following injection of poliovirus vacl 
theria, tetanus, and pertussis tr 
pneumococcal or meningococcal pol ' 
antigens. The use of live vaccines !e.•• 
ofCalmette-Guerin (BCG) or attenuat• I viruses) 
IS. The 
1 should 
uantita· 
ried out 
'S, diph-
•td, and 
tccharide 
Bacillus 
should always be avoided. Howe·. 
than j ust the total amount of an 
duced should be considered. The 
logarithmic, plateau. and decline ph 
tibody production should be measun• 
·r, more 
udy pro-
tduction, 
•s of an· 
' henever 
possible. The normal maturation of 1 , tmmune 
response (from predominantly IgM predomi· 
nantly lgGl ought to be followed. 
Absence of low serum levels of one c more im-
munoglobulins may have three poss t' causes: 
(1) absence or decreased numbers of B lis in the 
cit·cula lion and lymphoid tissue, (2l defect in 
immunoglobulin secretion by B cell!-. nd {3) an 
increased rate of immunoglobulin tnbolism. 
The following tests need t.o be can·iec u t to dis-
tinguish between these possibilit ies. 1 •termina· 
tion of lymphocyte membrane imm JOfluores-
cence with fluorescent antibodies . unst the 
various immunoglobulins can be used ' analyze 
the B cell population in the circulatio IS welJas 
in the lymph nodes. In addition, one c· •t look for 
the presence of germinal centers and pi •Hma cells 
in lymph nodes. The evalualiOJ of im-
munoglobulin catabolism can be detc rmined by 
measurement of the rate of disappeat tnce of ra· 
dioactivity from the circulation foliO\\ mg injec· 
t ion of radio-labeled immunoglobulin .... 
A complete evaluation of the B c- II syste!D 
should include analysis of the ampli ft, ttion sys-
tems belonging lo t he various types of ntibodies 
For instance, analysis of complemen fi xing an-
ti bodies can be carried out to detect t h ..;e types rl. 
TABLE 5-2 LABORATORY EVALUATION Of 
8 CELL FUNCTION 
1. Microbiolog ical studies, history of inft·•·ttons. 
2. Electrophoresis and immunoeleclrophm••sis 
of serum. 
3. Concentration of immunoglobulin clo"'t'' and sub-
classes in serum and secretions by r ad1al 1DllliUJlit 
diffusion. 
4. Tests for antibodies to ubiquitous anliJ!t'OS. 
5. Quantitation of humoral immune respon~e. 
6. Immunoglobulin receptors on lymphoc' tes by me~ 
brane immunofluorescence. 
7. Histology of lymph node biopsies, J{crminal center 
formation. 
B. Analysis of immunoglobulin cataboli!lm. o1 
9. Amplification of humoral immunity ('ompleme 
system. 
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laG utibody which are unable t.o activate the 
CliiiiiJ)Iement system. Evaluation of the comple-
IIIIDteyatem may also be necessary to determine 
tbelevelsof complementcomponents and some of 
tbe bameoetatic control mechanisms of the com-
plement system, s uch as Cl esterase inhjbitor. 
,.,, Immunodeficiencies 
Primary immunodeficiency results f1·om a fail-
ue to produce the effectors of the immune re-
.,._, i.e., antibodies and sensitized lympho-
eyta Excluded from thls definition are the 
hJpen:atabolic states and disorders in the ampli-
btion systems, such as the complement defi-
cieDeiel. Secondary immunodeficiencies may 
occur in patients with a variety of diseases. 
'l1le variabili ty of immunologic findings 
..-ta a major difficulty in classification of the 
priiDiry immunodeficiencies. Often neither etio-
Jap: u functional or structural considerations. 
tabD alone or together are satisfactory for ade-
..._dasaifi.cation of immunodeficiency diseases 
Ia 111111. Well-eharacterized diseases associated 
with primary immunodeficiency are listed in 
Tillie 5-3. However, the majority of patients with 
iluaaDodeficiency cannot be unequivocally clas-
liWud are ther~:.fore grouped under the head-
il(ohariable immunodeficiency. The probable 
.... at which various primary im-
.....s.&c:iency diseases interfere with normal 
~development are shown in Figure 5-3. 
OaiJ. rew will be selected for discussion. 
Patients with infantile, sex-linked agam-
lllllobalinemia (Bruton's agammaglobulinemia) 
TABLE 5-3 SELECTED PRIMARY 
IMMUNODEFICIENCY DISEASes· 
Suggested 
Dleotder 
...... • ·linked agam-
..:£:'"11Demia (Bruton's) ......_~unoglobulin 
~llgA) 
~~. ~li•YDdrome) ~ficiency 
:::-~ syndrome 
...,....;' leo..-y with 
Cellular Defect 
8 T Stem 
Cells Cells Cells 
+ 
+ 
+ 
+ + + 
+ + 
+ + 
+ + 
'=" ~11Dode6ciency 
- I + C+) 
., . •11.:~claaai6ca:tion is given in Fudenberg, H .. 
--.:., 47:927, 1971. 
have an immunodeficiency exclusively involving 
the B cell system while the functions attribuLa-
ble to the T cell system appear to be intact. 
Concentration of each of the immunoglobulins 
in serum or secretions is very low or absent, 
and humoral antibody responses are absent 
even to repeated injections of potent antigens. 
Histologic sturues show that lymph nodes 
and spleen of these patients lack germinaJ 
centers, and that plasma cells are absent ft·om 
lymph nodes, spleen, bone marrow, and connec-
tive tissue including the lamina propria (Figs. 5-
4A and B, 5-5A and 8 ). The tonsils have poorly 
developed lymphoid elements which lack follicu-
lar components (Fig. 5-6A and 8 ). By contrast, 
these patients have normal or nearly normal 
levels of circulating lymphocytes, nor mal 
numbers of lymphocytes in the thymus-depen-
dent regions of lymph nodes and spleen, and a 
normal thymus. Membrane immunofluorescence 
methods show absence of immunoglobulin recep-
tors on these lymphocytes. 
These patients usually have recurrent bacte-
rial infections which begin during the second six 
months oflife. They show extraordinary suscepti-
bility to infection with certain extracellular 
pyogenic pathogens like Pneumococcus, Strep-
tococcus, and Haemophilus, but. infections with 
other organisms like Staphylococcus and Pseudo-
monas occur only occasionaJiy. Many patients de-
velop pneumocystis infections. They suffer t·epea t-
edly from acute episodes of otitis, sinusitis, skin 
infection , conjunctivitis, a nd pulmonary disease. 
Such patients are also prone to septicemia and 
meningitis. In striking contrast, these patients 
can resist infections by many other microorgan-
isms including viruses, fungi, and most en-
terobacteria, even when they appear to produce 
little or no antibody t.o these microorganisms. 
They seem unable to resist infection with hepa-
titis virus, and s uch infections us ually cause ei-
ther massive liver destruction or chronic active 
hepatitis with steady progression to complete de-
struction of the liver. Patients with sex-linked 
agammaglobulinemia are prone to develop con-
nective tissue diseases such as arthritis, derma-
tomyositis, and diffuse vasculitis. Furthermore, 
they often develop malignant conrutions, espe-
cially in the lymphoreticular and gastrointes-
tinal tissues. 
Certain selective immunoglobulin deficiencies 
have been described which seem to be associated 
with defective development of a single im-
munoglobulin class. One of the most common 
primary immunodeficiency ruseases is the iso-
lated (or selective) deficiency of lgA which affects 
1 out of 700 persons. Most patients are clinkaUy 
asymptomatic but some may have recurrent gas-
trointestinal infections and a s pruelike syn-
drome. The incidence of rheumatoid arthritis, 
lupus erythematosus. tenosynovitis, and other 
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Figure 5-3 Possible sites of defect in the development of the lymphoid system of patients with var ous types ol 
primary immunodeficiency. (1) lmm u nodeficiency with generalized hematopoietic hypoplasia, reticular dysgene-
sis. (2) Autosomal recessive combined immunodeficiency. (3) Sex-linked and sporadic types of immunodeficiency. 
(4) Thymic hypoplasia (DiGeorge). (5) Ataxia-telangiectasia (6) Infantile sex-linked agammaglobulinemia. (1) 
Selective immunoglobulin deficiency (lgA), transient hypogammaglobulinemia of infancy. (8) Thymus dysplasia 
with normal immunoglobulins (Nezelof). 
mesenchymal diseases is higher in patients with 
selective TgA deficiency. A number of patients 
with low levels of IgA produce anti-lgA an-
tibodies which lead to decreased survival rate of 
serum IgA. Blood products containing IgA given 
to these individuals may result in anaphylactic 
reactions. Selective lgA deficiency causes low 
levels of lgA in serum as well as in secretions. 
The two subclasses, A, and A~, are usually re-
duced in equal proportions. However, in certain 
patients, low serum lgA levels are accompanied 
by normal concentrations of secretory IgA. The 
reverse situation may be present in other pa-
tients with IgA deficiency. 
Selective lgE immunoglobulin deficiencies 
have been described in children and are as-
sociated with frequent episodes of respiratory in-
fections developing into a progressive sinopul-
monary disease. 
Severe immunodeficiency disease of the 
thymus-dependent system is present in patients 
with thymic hypoplasia (DiGeorge syndrome}. In 
these patients there is a congenital arrest in the 
development of the thymus and parathyroids 
from the epithelial anlage derived from the ill 
and N pharyngeal pouches. Such infants w:ith 
hypocalcemic tetany at birth are unable to sur· 
vi ve because they lack the capacity to develop the 
T cell system and to express cell-med1. 1ted imJl!U· 
nity. Circulatin g lymphocyte counts ure usu~Iy 
near normal at birth but soon decline tn a signtfi· 
cantly low level. These patients fa il to expre~ 
any of the functions of cellular im munity B.? 
have a high susceptibility to fungal and viral.1°' 
fections. By contrast, their levels of Jill' 
munoglobulin are normal, plasma cells a:e 
present in normal n umbers in the lymphoid us· 
sues in bone marrow, and the thymus-indepen· 
dent regions of lymph nodes and spleen are ~~ 
preserved. The thymus-dependent, deep cortJ bs 
areas of lymph nodes and periarteriolar sheal 
of splenic follicles are depleted of lympboc~f 
(Fig. 5- 4C). Infections usually begin early in ~ 
and may be caused by fungi, viruses. atYP1 d 
acid-fast organisms, low-grade and high·gt8 .~ 
, I~ 
encapsulated bacteria, and Pneumocystis cannaf. 
Severe combined immunodeficienc.) disease · 
fects both B and T cell systems. The aut.osorosl 
recessive variant of this alymphocytic agalll' 
maglobulinemia bas been called Swiss t)'J* 
agammaglobulinemia. These patients have ~ 
vere cellular defects in the development of h 
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.. 
•'="Didl-4 Lymph node histology In primary immunodeficiency. A, Stimulated lymph node of a normal 11-
-. Child. Well-developed germinal centers and abundance of plasma cells . The cortical and deep cortical 
., .. densely populated by lymphocytes. 8, Lymph node from a boy with infantile sex-linked recessive 
-::wlnemla 5 days after secondary antigenic stimulation. Absence of cort ical germinal centers and 
....., dense populations of small lymphocytes in the deep cortical regions. a n d lymphocyte depletion in ._;.~ymph node from a patient with thymic hypoplasia. The thymus-dependent deep cortical regions are 
.... ._ ~I lymphocytes. Lymphoid follicles. germinal centers. and plasma cells are present. 0, Lymph 
--~ld with autosomal recessive combined Immunodeficiency disease. Severe depletion ot lympho-
~ot~ cells ~ccompanied by histiocytOSIS and stro m al hyperplasia. (Courtesy of Dr. Robert A. Good, 
-Kettertng Institute, New York.) 
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Figure 5-5 Histology of spleen in primary immunodeficiency. A. Spleen of a child who died of c?nge~ 
heart disease at 3 months of age. Note the normal dense lymphoid cellu larity of the malpighian ~oii 1Cies loP" 
several germinal centers. B, Spleen from child with sex-linked agammaglobulinemia. Note the pnmit1ve de~es 
ment of lymphoid follicles and absence of germinal centers and plasma cells. C, Severe depletion of lymph r1es1 
and plasma cells in spleen from patient with autosomal recessive combined immunodeficiency disease. (Cou 
of Dr. Robert A. Good. Director of Sloan-Kettering Institute, New York.) 
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.::; 1-t A, Normal tonsil lar tissue with abundanc~ of lymphoid elements. 8 , Tonstl from a pattent wtth .._YIIIt.~·Hnked agammaglobulinemia. (Courtesy of Dr. Robert A. Good. Dtrector of Sloan-Kettering lnstttu te, 
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moral as well as cell-mediated immunity as a 
consequence of a lymphoid stem cell defect. Very 
young infants are affected by this disease and suf-
fer recun-ent infections with a great variety of 
microorganisms. They generally succumb during 
the first year of life to low-grade, opportunistic 
pathogens such as Pseudomonas, Staphylococcus, 
the common enterobacteria, Pneumocystis 
carinii, and Candida albicans. If exposed to 
meas les virus, they may die of a characteristic 
giant cell pneumonia (Hecht's pneumonia); they 
do not show the characteristic measles rash. Also, 
progressive, generalized vaccinia will occur after 
dermal smallpox vaccination. 
Serum levels of all immunoglobulin classes are 
either absent or ext1·emely low. The thymus is 
hypoplastic and lacks lymphoid cel ls and Has-
sail's corpuscles (Fig. 5-7). These patients have 
severe lymphopenia and an absence or marked 
deficiency of lymphocytes in the thymus-depen-
dent as well as the thymus-independent regions 
of peripheral lymphoid tissues (Fig. 5-4C and D ). 
In addition to the Swiss type of agam-
maglobulinemia, a large number of patients have 
lymphopenic immunodeficiency syndrome which 
varies greatly in the clinical and laboratory man-
ifestations. Some of these patients are clearly of 
sex-linked recessive inheritance, others seem to 
be inherited as autosomal r-ecessive tr-aits, and 
still others have thus far not revealed any heredi-
tary patterns. Laboratory evaluation of both T 
and B cell systems show variability of im-
munodeficiency. Some patients with these forms 
of combined immunodeficiency possess nearly 
normal amounts of IgM, little IgG, and no IgA. 
Different degrees of defective devcl··. ment of pe-
ripheral lymphoid organs and t h:-. n .~ have also 
been observed. 
Immunodeficiency of the B cell ystem, and 
especially of the T cell system, i~ <!• .-uuntered .in 
ataxia-telangiectasia (Louis-Bat syndrome). 
These patients develop a progrel:'~i e cerebellar 
ataxia which usually begins durin£; .he first few 
years of life. They often have rec.;·-rent pulmo. 
nary infections and develop promin• nt telangiec-
tases in the sclerae, the skin or th eyelids, the 
ear lobes, the neck, and the poplil< t1 and ante-
cubital spaces. These patients h.:,·e variable 
degrees of deficiency of the cell .. ediated im· 
mune responses. In some instam ~ they show 
deficient antibody production to ·~rtain rela· 
tively weak im:munogens. A la1 ~·· percentage 
have low levels of IgA and Igr 1s a conse-
quence of decreased rate of syn ,1 :esis of the 
immunoglobulins. Several pat.iP•· · have an 
increased rate of IgA catabolism ht•cause of the 
presence of anti-IgA antibodies. 1 tstologically, 
the thymus-dependent regions of the peripheral 
lymphoid tissue show a depletior • f small lym· 
phocytes. The thymus is small , ''"tcks Hassall's 
corpuscles and is poorly organizeo ;nto a co~ 
and medulla (Fig. 5-8). Female t·hildren ~V_Jtb 
ataxia-telangiectasia frequently ~how ovanan 
dysgenesis. The etiology of this au wsomal reces-
sive disease is not well understQ,.t[, but may be 
due to a neuroendocrine abnormhl ty. These pa· 
tients have a relatively h.igh su -· eptibility to 
malignant disease, in particu lflr. lymphosar· 
coma, reticulum cell sarcoma, or reticuloen· 
dotheliosis. 
Figure 5-7 The hypoplastic tilt 
mus lacking lympho•d elements and 
Hassalrs corpuscle 1s a salient fea-
ture of autosomal recessive com-
bined immunodeficiency dise;: 
(Courtesy of Dr. Robert A. ~ e 
Director of Sloan-KettennQ lnst•tul 
New York.) 
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,._. 1-1 Thymus In ata)( la-
~~~~ng~~et~~la. Severe lymphoid de-
pilliOn In bOth cortex and medulla. 
Hlllll't corpuscles are absent 
fCourt11Y of Dr. Robert A. Good. 
1J111C111r of Sloan-Kettering Institute • 
._York.) 
fte Wiakott-Aldrich syndrome is a sex-linked 
.._cbaracterized by a central thrombopenia, 
-.and marked susceptibility t.o many infec-
.... Patiente with this syndrome lack Lhe nor-
.a ilohemagglutinins and hemolysins and fa il 
ltJI'OIIace antibodies to polysaccharide a ntigens. 
., Cllllllrut, the humoral a n tibody response 1.o 
....... IUc:h as tetanus toxoid is normal. In 
.... petiente a progressive deficiency of cell-
....._. immunity develops. Like the patients 
_. l&aia-telangiectasia, a high mcidence of 
~ar malignant conditions is found. 
,_ ..upant conditions may rapidly become 
d4t¥wd and seem to have great propensity to 
._.. the central nervous system. [ l appears 
Ill tile buic immunologic defect in these pa-
._ ia..,avee the afferent limb of the immune 
...... and perhaps resides primarily in the 
~processing of antigen. 
.:::. &a with a benign spindle cell tumor of the 
bave been described as having hypogam-
-.1 I I ;:..h»mia, antibody deficiency syndrome, 
t1 cellular immunity, and often an ab-
:-,tl tllliDophils. As with other hypogam-
,.( 41nemic patients, they are prone t.o de-
tr aotlmtia and other a u toallergic and 
'-iillrs_. diaeases. 
.... !P'aP of variable immunode fici ency dis-
.. ilchidea many syndromes which a re not ~ Included in this group are cases ~ dueified as "congenital" nonsex-
WipOhdic hypogammaglobulinemia, pri-~mmaglobulinemia" of both childhood 
..... I I lite, and "acquired" primary hypogam-1~. 
Treatment of Immunodeficiency 
Considerable improvement is achieved in pa· 
t ients with B cell deficiency by replacemenllher-
apy with gamma globulins. Special precaulions 
s hould be taken lo avo1d infection by hepatitis 
virus which frequently causes lethal li ver dibease 
in these patients. Some patien ts with thymic 
hy poplasia have been successfully treated with 
fetal thymus transplants. Although these trans· 
plants came from hist.oincompatible donors, Lhey 
were able to reconstitu te T cell function for a con-
s iderable time. Combined immunodeficiency dis-
ease can be corrected by transplanting a source of 
ly mphoid stem cells, usually the bone marrow . 
The development of grafl.-versus-hos l disease is a 
serious complication, because the bone marrow 
gives rise Lo a population of immunocompetent 
Lymphmd cells which make an immune response 
against Lhe hist.oincompatible ~nd im-
munologically incompetent host. Identity across 
the HL-A histocompatibi lity locus is generally 
required for the s uccessful acceptance of these 
bone marrow transplants. 
Disorders of Immunoglobulin Metabolism 
T hese may occur secondarily to a variety .or 
pathophysiologic mechan isms. As has been diS-
c ussed above, hypogammaglobulinemia may be 
due to a primary immunodeficiency of the B 
ly mphocyte system affecting one or more classes 
of immunoglobuli ns. Alternatively, hypoga.m-
maglobulinemia may be secondary to excess1ve 
loss of immunoglobulins into the urinary or gas-
trointestinal tracts. Finally, abnormal im-
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munoglobulin levels may be secondary to dis-
orders of endogenous immunoglobulin catabolic 
pathways. Accelerated catabolism may affect one 
or more immunoglobulin classes. 
Accelerated catabolism of IgG has been ob-
served in patients with myotonic dystrophy. This 
autosomal dominant disorder is characterized by 
myotonia, muscle wasting, premature baldness 
and testicular atrophy, cataracts, and electrocar-
diographic abnormaUties. The serum levels and 
metabolism of albumin, IgM, IgA, IgD, and IgE 
are normal. In contrast, serum levels of IgG are 
markedly reduced as the result of an accelerated 
catabolism. 
An increased rate of catabolism oflgA has been 
observed in patients with iso.lated IgA deficiency 
or ataxia-telangiectasia, when they produce anti-
IgA antibodies. 
Alternatively, generalized hypercatabolism of 
many serum proteins, including immuno-
globulins, is often present in patients with 
Wiskott-Aidrich syndrome or with familial hy-
percatabolic hypoproteinemia. Elevated urinary 
or serum levels of immunoglobulin light chains 
are observed in patients with tubular proteinuria 
or uremia when the normal site of catabolism of 
these molecules, the proximal convoluted tu-
bules, is damaged. 
Disorders of the Complement System 
A variety of genetically determined abnormali-
ties of the complement system have been de-
scribed. These can be classified as (1) defects in 
inhibitors which result in the spontaneous con-
sumption of complement components, (2) synthe-
sis of defective complement molecules, and (3) ab-
sence of a complement component. 
Hereditary angioedema is caused by a defective 
synthesis of Cl esterase inhibitor. In normal per-
sons, Cl esterase inhibitor blocks the activity of 
Cls and is therefore capable of suppressing the 
progression of the complement sequence beyond 
Cl. This enzyme also inhibi ts the activity of cer-
tain enzymes active in the clotting system, in-
cluding the Hageman factor , plasmin, and pre-
kallikrein. Patients with hereditary angioedema 
suffer from episodic triggerings of the comple-
ment system and develop severe angioedematous 
reactions in various tissues, particularly those of 
the upper respiratory tract. It is unclear why 
these patients have episodic disease, but trauma, 
menstruation, and infections may precipitate 
clinical crises. This disease may be observed at 
any age but usually first manifests itself during 
late adolescence or early adult life. The recurrent 
attacks of edema are mostly confined to skin, gas-
trointestinal tract, and respiratory mucosa. The 
edema is nonpitting and nonpruritic. The epi-
sodes last for about 48 to 72 hours. The involve-
ment of the larynx is most sen • ' .md many pa· 
tients may die from suffocat Hereditary 
angioedema exists in two geneti nants.ln one 
type no Cl esterase is produced .. r I in the other 
the protein is made but is not I' tiona!. 
Patients with a defect in C3 ,. , .11>olism as the 
result of an abnormal activity '' proactivator 
suffer fi·om fi·equent recurrent ogenic infoo· 
tions. Familial C5 dysfunction h , - •een described 
in patients with Leiner's syncLc e who suffer 
from generalized seborrheic der. · lliis, intracta· 
ble severe diarrhea, recunent J,, and systemic 
bacterial infections usually of g 1 1- negative eli· 
ology, and a marked wasiin... ,d dystrophy. 
Deficient opsonic act ivity of t.bt· lient's serum 
with yeast cells is the diagnoslic "boratory find-
ing in this disease. 
Autosomal recessive C2 deft• · '·v is usually 
not associated with any clin c•. disease. Al· 
though the sera of these paticn• 1re extremely 
defective in hemolytic activit) . 1.1 my biological 
functions of the complement S\ tem, like im· 
munoadherence and facilitalion ' t phagocytosis, 
seem unimpaired. It appears th o~ t 2 deficient in· 
dividuals have an unusua lly h\~ 1 incidence of 
hypersensitivity disease. 
Patients with the autosomal r<·•'!!SSive form or 
combined immunodeficiency di.,t>ase have ex· 
tremely low serum levels of C l l'. S ince Clq ~as 
an electrophoretic mobility of a g uu ma globuh~. 
it is particularly interesting t h.•t this protem 
should be defective in patients lu Kmg both Band 
T lymphoid cells. In contrast, pal il'nts with set· 
linked, recessive combined imn1t'nodeficiency as 
well as the various form!; ol hypoga!llDlJI· 
globu1inemia show only sl igl·t to moderate 
reduction of Clq levels. 
Experimental strains of mice und rabbits hal'e 
been described which lack C5 and C6, respt!C' 
tively. Low serum levels of complc•ment canal~ 
be observed secondary to a vatil'ty of disease5> 
particularly in immune complex di::;easessucha! 
acute glomerulonephritis, syslem1c lupus e~ 
matosus, and poststreptococca l glomerulonep · 
tis. 
Secondary 
Immunodeficiency Diseases 
. · ha''l! Although pr imary immunodeficlencle~ ses 
received considerable attention. these :d~lll' 
are rather uncommon. ln contrast, depre COil' 
mune function occurs quite frequently as 8 ·aJif 
sequence of various disease states, espec~ 
those that cause disturbances in general me dan.' 
lism and which induce stress. These seco~ ~ 
immunodeficiencies are frequenlly .observ1 1*: 
certain infections, malignant cond•t•~ns 10: J 
cially of the lymphoid system I, excess•veh raP>· 
proteins or cells from the body. dr_u~ t t illl' 
debilitating diseases, and aging. Clln~caJ Y· 
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mUDOCieficiency is first indicated by more 
trequent and persisting infections with one spe-
c:i6c microorganism or a var iety of microorgan-
.._ Secondary immunodeficiencies may affect 
both humoral and cellular immune systems, and 
may operate at the induction (afferent. limb) or 
~ion (efferent limb) of immunity. The 
JDitbods of evaluation of humoral and cellular 
imJDilDe function in patients with suspected sec-
OIIIIaryimmunodeficiency are listed in Tables 5-l 
111116-2. 
c.tain infections may lead to dec1·eased im-
IIIUD8 function. For example, secondary im-
muadeficiency is usually present in infants with 
CIJIII8Dital rubella syndrome. Infection with ru-
bella virus is contracted during the second and 
tiUrd 010nth of gestation. These patients have a 
CllldiDuing active viral infection from birth up to 
18 IIIODths of age and produce antiviral an-
tilladiea, primarily of the IgM type. Increased 
.amlgM levels are frequently accompanied by 
-wly reduced IgG concentrations; oc-
CIIiaaally there is a generalized hypogam-
~inemia. During active rubeUa infection, 
PldpberaJ blood lymphocytes may fail to undergo 
~lutinin-induced blastogenesis. ln-
llr:liaaa with measles (rubeola) virus frequently 
...._ a temporary loss of delayed hypersensi-
tlti&J. Tuberculin-positive patients may tempo-
..n, loee their ability to express a delayed al-
llrliC reaction to tuberculin protein during a 
...... infection. Lymphocytes from these pa-
llllllare unable to respond with blastogenesis to 
...... although their responsiveness to phyto-~~~in or other mi'togens is unaltered. 
infected by Mycoplasma also have 
"bed ability to r espond to antigenic and 
-....me stimulation. ~ immunoproliferative diseases are accom-
- by a secondary immunodeficiency state. 
-.....&!proliferation may affect the B and T ;: ;-nme systems. Best known are the secret-
a.;;_ .U tumors, which include multiple mye-~ ·~~trom's macroglobulinemia, and 
... ~ disease. These disorders have often 
- the monoclonal gammopathies be-:...theee plas~a cell tumors produce excessive 
....... of an ammunoglobulin of sh arply res-
... 11101ecular heterogeneity. These parapro-
... -.y be of any one of the immunoglobulin 
-.,. UJd may have the same basic molecular 
~- aa their ~ormal counterparts. An excep-._.,•~protem of heavy chain disease which 
..a )ICil't.ion of the Fd fragment of the heavy ~ p. 100). Since numerous myeloma pro-bee~ found to have antibody specificity 
.....:,~tige~, it is currently believed that 
~ PJ'Ote1ns are antibodies of restricted 
-.-; llpecificity. Light chains of either .....,~types may be produced in. excess 
and may circulate as free dimers 
of homogeneous light chains. Because of their 
small size they are rapidly excreted in the urine 
(Bence Jones proteins) . 
Patients with multiple myeloma often suffer 
from recurrent infections with Pneumococcus and 
other highly pathogenic bacteria. They have no 
unusual susceptibility to infections with staphy-
lococci, enterobacteria, or fungi. Severe defi-
ciency of the B cell immune system can be demon-
strated by the low levels of serum 
immunoglobulin and seems to be a result of de-
creased synthesis of normal immunoglobulin 
molecules. Antibody synthesis against ex-
ogenously administered antigen is markedly dell-
dent. lo contrast, cellular immune function is 
grossly normal. 
Patients with Waldenstrom's macroglobuline-
mia have excessively high serum levels of a high 
molecular weight protein which has the chemical 
and immunochemical characteristics of lgM. Be-
cause of the high intrinsic viscosity of IgM pro-
tein, these patients have increased viscosity of 
the serum. which leads to sl uggish blood flow, 
thrombosis, central nervous system disturbances, 
and bleeding. Most commonly affected are the 
skin, nasal mucosa, and gastrointestinal tract. 
Sluggish blood flow of the retinal vessels may 
eventually cause thrombosis of retinal veins and 
blindness. Frequently, the patient's red cells, 
granulocytes, and particularly platelets may be 
coated with macroglobulins, which results in im-
paired survival and function of these elements. 
Lymphadenopathy and hepatosplenomegaly are 
salient. features. Hyperproduction of IgM macro-
globulin is often accompanied by decreased syn-
thesis of other immunoglobulins. Many patients 
produce detectable amounts of monomeric, low 
molecular weight macroglobuljns (7S IgM). Ap-
proximately 10 per cent have demonstrable 
Bence Jones proteinurea. 
The recent elucidation of the structure of the 
immunoglobulins (see p. 101) and the detailed 
characterization of the proteins in serum and 
urine of patients with proliferative disorders of 
plasma cells and lymphocytes have led to a better 
understanding of the biosynthetic alterations ac-
companying these disorders. These diseases are 
now frequently classified on lhe basis of the prod-
ucts of the neoplastic cells. Multiple myeloma is 
defined by the type of immunoglobulins produced 
(G, A, D, and E myeloma}, and the biosyntbetic 
processes in myeloma and macroglobulinemia 
can be either t..be balanced synthesis of heavy and 
light chains, resulting in homogeneous serum im-
munoglobulin, or the unbalanced synthesis mani-
fested by the presence of light and occasiona11y 
heavy chains as an additional, or at times, the 
sole detectable product. In addition, the recogni-
tion of several new disorders of immunoglobulin 
synthesis has resulted in the identification of a 
number of new syndromes. Best described among 
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these are the group of heavy chain diseases which 
represent examples of abnormal immunoglobulin 
synthesis and assembly. Three types of heavy 
chain diseases corresponding to the heavy chains 
of IgG (gamma), lgA (alpha), and lgM (mu) a re 
now recognized. Gamma chain disease is most 
frequently seen in the middle aged and elderly. A 
rather characteristic clinical picture which re-
sembles a malignant lymphoma rather than mul-
tiple myeloma includes lymphadenopathy and 
hepatosplenomegaly. Involvement of the nodes of 
Waldeyer's ring resulting in palatal edema is 
particularly striking. Almost all patients suffer 
from frequent episodes of infection. Anemia, leu-
kopenia, eosinophilia, and hyperuricemia are 
common but are relatively nonspecific laboratory 
findings. Definitive diagnosis of gamma chain 
disease can only be made by immunochemical 
analysis of serum and urine proteins. Character-
istically, there is a broad peak with a mobility of 
a beta globulin present in both serum and urine. 
Amino acid sequence analysis of gamma chain 
disease proteins has demonstrated deletion of 
most of the Fd fragment as a consequence of loss 
of interchain disulfide bridges. Alpha chain dis-
ease has been found in patients with malignant 
lymphoma involving the small intestine and is 
usually associated with severe malabsorption. A 
few cases of mu . chain disease have been de-
scri~d in patients with chronic lymphocytic leu-
kerrua. 
Pa~ien~ with Hodgkin's disease develop a pro-
gressive Immunodeficiency of the cellular im-
mune system while humoral immune function 
appears essentially normal. Both the afferent and 
efferent limbs ofT cell-mediated cellular immu-
n~~ ar~ deficient. Although patients with Bodg-
~m s dis~ase have a normal resistance to infec-
tions W1th Pneumococcus, Haemophilus, and 
Str_eptococcus, they are susceptible to tubercu-
losis and fungal infections. 
Patients with chronic lymphocytic leukemia 
develop deficiencies of both the T and B cell im-
~une systems: Both immune systems are essen-
tially normal m acute lymphocytic leukemia In 
later_ ~bases of these lymphoreticular malignant 
~ndibons, ~pparently as a consequence of con-
tinuous anttcanc:er chemotherapy, defective host 
defense mech~msms allow recurrent infections 
to become an lllllllense problem. 
. The lymphoreticular malignant condit" lik~ the lymphocytic leukemias, the Jympho~::· 
retlculum cell sarcomas, and Hodgkin's disea ' 
have thus far been classified on . se, 
morphologic and clini 1 b . the basts of 
. h ca o servatJons. However 
Wit r~spect to our rapidly expanding know led ~ 
of the 1rnmunelympboid system ·t · d · g 1 ify h . , I 1s a vtsable to 
c ass. t ese proliferative disorders accord' 
functiOnal characteristics of B d T 1 mg to 
cytes Expe · . an Ympho-
chr . . l . ~men~al evidence indicates that 
omc ymp ocytlc leukemia is probably a non-
secreting B cell leukemia and t't-': n forms or 
ma lignant lymphoma are T cell 1 • 11 ,.,. 
Patients with nephrotic syndt • • have low 
serum levels of a lbumin and ~·• · 1 globulin 
because the excessive amounb ol -e proteins 
are lost in the urine. ConscqUL'llll these pa· 
tients are very susceptible lo in · • •ns by en-
capsulated microorganisms a~; ,. as gram. 
negative bacteria. Nephrotic pu 1 L~ respond 
well to immunogenic stimuli nil' pccific an· 
tibody is rapidly lost in the urirh" tl! mosl af. 
fected immunoglobulin is lgG. wit~ I• 1•~ .11 1 and the 
beta and alpha globuli ns of the ''' Pment sys· 
tern are norma l. This is also lhl in classic 
lipoid nephrosis of children. In ro -t. patients 
with acute glomerulonephritis fill I • t tain forms 
of chronic glomerulonephritis nut \ lose pro-
tein in the urine but a lso depo:-11 mune com· 
plexes and complement in their 1 •evs. These 
patients may have complemt• d;ficiencies 
because of an excessive rate of ut 1 • tl ion. Some 
patients with hypocomplemenh' forms of 
chronic renal disease may have u reased rate 
of synthesis of complement con 1 tcnls. espe-
cially C3. These patients have ad 1ished abil· 
ity to develop inflammatory resp ~. 
Protein losses from the intestu .ract during 
certain acute and chronic disea~ , ,f the bowel 
may lead to bypogammaglobuli nl In intesti· 
nal lymphangiectasia, both seru • Proteins and 
lymphocytes a re lost in the stool Hl'h patients 
have low immunoglobulin Jevek I. mphopenia. 
and deficient immune function o1 ') 11 h B and T 
cell systems. 
Patients who have sustained n · r bum inju· 
ries develop immunodefi ciencies. A • .1nsient by· 
pogammaglobulinemia may occr• during the 
first week because of losses th' 111 :h the burn 
lesions. Increased synthesis of 1 nu unoglobulins 
overcompensates for these losse" week lat.er. 
Lymphocyte depletion occurs a" n•sult of de-
struction of lymphocytes under th nfluenceof_a 
stress-induced increase of adn·rh ·orlicosteroJd 
production. The markedly decrea:-• r resistance of 
burn patients to infections is mu111h due to t~el 
relative inabili ty of their neu , phils to kJi 
phagocytosed bacteria. 
TUMOR IMMUNOLOGY 
Tumor-Associated AnUgens (Tumor-
Specific Antigens) 
The majority of tumors, incl ud111g those in: 
duced by chemical carcinogen:- , nd viruses,~ 
~ell as spontaneously arising lumCirs. carry 3~ 
tigens w~ich elicit immune responsi'S ~n the hOSts 
Tumors 1_nd~~d by chemical m· plnstcaJ ag~al 
express mdtv1dually distinct an ll!cns so 1 . 
cross-immunJzaLion is rarefy pn~s1hle even 10 
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tumon of similar morphology induced by the 
.- carcinogen. In contrast, virus-induced 
tumon contain cross-reacting antigens showing 
~related specificities. Immunization against 
0111 tumor may lead to protection against other 
tuiiiOI'I induced by the same virus. This dif-
flnace in the specificities of antigens associated 
with tumors induced by chemical carcinogens 
IJIIIICIIICOgellic viruses has provided a method for 
clelermining the etiology of spontaneous tumors. 
SiJiceeeveral virus-induced tumot·s have recenlly 
beeubown to have individually speci fic an ligens 
belidel the common antigens coded for by the 
Yinll, this distinction is less clear and definition 
Gltbe antigenic tumor specHicities does not pro-
Qiecoodusive evidence of its etiology. In addi-
tioD,IeVeral chemical carcinogen-induced t.umors 
Dalate the production of antibodies which 
a.-react with antigens associated with certain 
..... 
'l'bere are two ml\)or categories of tumor-as-
.ut.edantigens in virus-induced neopl asms: (1) 
the 9irus-specific antigens and (2) the newly 
"-1 antigens, i.e., the antigens Lhat were not 
..-t in the normal cells before neoplastic 
lrlllbmation, or on the virions. Antigens 
~to the latter category may a r ise as (al 
~ of a specific interaction of the viral 
.... with the host genome, (b) a specific un-
.....q of normal or preexisting (embryonic?J 
Cllllprodw:ts, or (c) as a consequence of derepres-
liiiiGlintracellular type-C RNA viruses. 
'1\e virus-specific antigens may be structural 
~tsofthe virion or virus-coated products 
 by the n eoplastic cells. Although 
~ IDtigena are frequently demonstrable in 
- tirua-induced neoplasms, Lhey are rarely 
-it tumors induced by DNA viruses. In leuke-
:::. iadw:ed by RNA viruses, cell surface an-
lllay be shared with those of the virion. ·~--ma~ure at the cell membrane by bud-
ad the vtrus particles wbkh are continu-
-~ by the leukemic cells receive an outer 
.,.. the cell membrane. '-ar-~peeific antigens in DNA virus-induced ~~~ ~ .not identical with the antjgens of 
vtnon and are present even when in-
~ beYU'WI production by the transformed cells 
Illite ~monstrated. Since these antigens 
tpecifically to the inducing virus, their C::: and permanence suggest that viruses 
•.a :..least part of their genetic information in 
"---~p~astic transformation. In view of 
~-.-ctlvtty of cells of different types and 
t.& the tumors in different species, it is likely 
~Dew antigens on the surface of DNA 
... UCed tumor ceUs are determined by t.he a,~·. On the other hand, tumors induced 
............ VIrUses do n ot cross-react., even when 
...... are morphologically similar and are 
il tbe same species. Exceptions to these 
rules for cross-reactivity of chemical- or virus-in-
duced neoplasms may occur when the trans-
formed cells express new antigens related to dere-
pression of certain bost genomes or of intracell-
ul a r virogenes. 
Derepression of cell genome-coated products 
occurs in certain types of tumors giving rise to 
t u mor-associated antilgens which cross-react with 
antigens found in embryonal tissue but not in 
adult host tissue. Most frequently described are 
the carcinoembryonic antigen of carcinoma of the 
colon and the alpha fetoprotein associated with 
hepatic malignant disease in man. The relation 
between the appearance of these embryonal an-
tigens and neoplastic transformalion is not clear, 
since carcinoembryonic antigen has recently 
been found in colonic and other gastrointestinal 
t issue in patients with various non-neoplastic 
disorders. Several experimentally induct-d tu-
mors also express emlbryonal tissue antigens . 
Recent. studies support the concept that ver-
tebrates cont.ain t.he genetic information for pro-
ducing type-C RNA tumor virus i n an unex-
pressed form in their somatic cells as well as in 
their germ cells. The viral oncogene theory pro-
poses that the endogenous virogenes (the genes 
for production of type-C viruses) and Lhe on-
cogenes (that portion of the virogeoe responsible 
for transforming a norm al cell into a neoplastic 
cell) are maintajned in an unexpressed form by 
repressors in normal cells. Various agen ts, in-
cluding radiation, chemical carcinogens, and ex-
ogenously added viruses, may transform cells by 
"switching on" the endogenous oncogene infor-
mation. It is under these conditions that the 
major i ntemal antigen of type-C virus, the group 
s pecific or gs antigen can be detected i n tumorous 
tissue. 
One approach t.o studying Lhe etiology of 
h u man malignant. disease has been the detection 
of immunologic cross-reactivity in a variety of 
human tumors. Since all tumors induced by the 
same virus contain common tumor-associated an-
tigens, while neoplasms induced by different 
viruses or by nonviral carcinogens usually lack a 
common antigenicity, one would anticipate a 
common viral etiology from neoplasms possessing 
common tumor-associated antigens. However, 
immunologic cross-reacti vity between t.umors 
can be due to the presence of embryon ic and gs 
antigens or antigens indu ced by virus infection of 
tumor cells. Patterns of cross--reactivity have 
been demonstrated between antigens associated 
with a variety of tumors. Various human cancers 
origi nating in the same organs appear to share 
antigens recognized as foreign by the immune 
system of the patient. while being undetectable in 
normal cells of the aame organ. Certain human 
tumors share common antigens not found on 
other tumors. They include neuroblastoma, mam-
mary carcinoma, endometrial cancer, colonic car-
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cinoma, bladder tumors, and malignant melan-
omas. These observations suggest a viral etiology 
for the majority of human neoplasms, provided 
that one postulates that there is a large array of 
viruses, each of which is associated with neo-
plasms of a certain origin. This could be the case 
for RNA viruses, which are us ually specific for 
the type of tumor and organ affected. Unfortu-
nately, ther·e are no data to support the hypoth-
esis that these human tumors are induced by 
tumor viruses. On the other hand, there is evi-
dence that common antigens detected in Burkitt's 
lymphoma and nasopharyngeal tumor are as-
sociated with the presence of Epstein-Barr (EB) 
herpes type virus in t hese neoplasms. The ques-
tion to be resolved for these neoplasms is whether 
they carry EB virus as an etiologic agent or as a 
passenger virus. 
Demonstration of Tumor Immunity 
It is generally accepted that both cell-mediated 
and humoral immune response play a major role 
in host-tumor relationships. Histologic evidence 
of tumor immuruty is indicated by the infiltration 
of several types of tumor by mononuclear lym-
phoid cells, which is frequently accompanied by 
increased cellularity of the regional lymph nodes. 
For instance, in malignant melanoma, this ap-
pearance is most frequently found around pri-
mary tumors and early tumor·s. The lymphocellu-
lar response usually decreases as time elapses 
and the tumor grows. Increased proliferation of 
mononuclear cells in t he regional lymph nodes 
and infi ltration of lymphocytes and plasma cells 
around the periphery of the tumor have often 
been associated with a favorable prognosis of pa-
t ients with various types of malignant disease 
(e.g., mammary carcinoma, gastric carcinoma, 
malignant melanoma, testicular seminoma, and 
urinary bladder tumor). 
Several in-vitro tests have been developed to 
analyze humoral and cellular immunity to tumor 
cells. H umoral antibodies can be demonstrated 
by tests for cytotoxicity, membrane im-
munofluorescence, and mhed hemadsorption and 
immune adherence. Cytotoxicity tests determine 
tumor-specific antibodies which, in the presence 
of complement, exert a cytolytic effect on tumor 
cells. Although these cytotoxicity tests may be 
useful in determining humoral immunity to lym-
phoma and leukemia cells, they rarely work for 
sarcomas and carcinomas. Cell surface antigens 
are demonstrable by membrane immunofluores-
cence in Burkitt's lymphoma and naso-
pharyngeal carcinoma in which cross-reacting 
antigens associated with the EB virus can be de-
tected. 
Cell-mediated immunity to malignant disease 
has been demonstrated by use of in-vitro assays 
with tumors from experimental animals as well 
as in man. These tests are based or •e fact lhal 
tumor-specific immune lymphoc' UJX>D in-
teraction with tumor cells, can h1 ·tivated to 
produce soluble factors, lymphoktn which par· 
ticipate in the amplification "-' m of cell· 
mediated immunity and which m \ cad to de-
struction of the tumor cell. T he n.: . ,,. evidence 
for cell-mediated immune retH 1 '•Jils against 
human tumors has come from stud performed 
with the colony-inhibition techniqn l'umor cells 
are first grown in vitro and are ll , CXJX>Sed to 
tumor-specific immune lymphocytt' rhe inhibi· 
tory effect. of these lymphocytes ~~ -cssed by a 
reduction in the number of t01 ,'O)orues as 
compared t.o the effect with nonitP ne lymph& 
cytes. 
The fit·st human tumor to be Ired by the 
CoJony-inhibit.ion technique WaS II rob)astoma. 
It. was found that peripheral blood vmphocytes 
from patients with such tumors in i111 1!Led colony 
for·mation of neuroblastoma cells. \' hct.her they 
were of auLochthonous or allogent•l ur·igin. Nor· 
mal skin fibroblasts from tumor do ·l'S were not 
inhibited. Lymphocytes from • tients with 
tumors other than neuroblaston • and from 
donors not having cancer did not nhibit these 
neuroblastoma cells. Thus, the I~ 1ocyte effect 
was specific and could not be attn I • ·d to immu· 
nity to normal alloantigens. The,., >hservatioDS 
also implied that neuroblastomas I t• a common 
tumor-associated antigen. 
Similar results have been oblattwd with the 
colony-inhibition test in a large VHI II'IY of hum~ 
malignant conditions (Table 5-4 1 In many rn· 
TABLE 5-4 ANTIGENIC CROSS REACTIVITY 
BETWEEN TUMORS OF THE SAME TYPE 
Number of Patient·Tumot 
Cell Combinations 
P ositive Per Number of 
Tumor Type Comb/nat1ons Tested' 
--------------------------- -------
Melanoma 
Colon cancer 
Breast cancer 
Lung cancer 
Sarcoma 
Endometrial cancer 
Ovarian cancer 
Testicular tumor 
Squamous cell cancer 
Kidney cancer 
Wilms' tumor 
Parotid tumor 
Total 
-tl 41 
:L!i/31 
I ~/ 14 
fi'6 
.!3 
2 3 
.!5 
" 10 
- "l 
l I 
112 
I I 
( ll:l !19 t87'fl 
•Tumor patient lymphocytes were (l',tcd on l~ 
tumor cells derived from different donor' ull hav.np Or 
same type of neoplasm. [nformati(jn n1urtcs~ 0 
K. E. Hellstrom. 
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l&aJIC88, the speciiic in hibition of colony forma-
tioa by lymphocytes from patients with a certain 
type of tumor has provided evidence of antigenic 
~reactivity withi n (but not between) groups 
fltumors of the same morphology. 
Several neoplasms in experimenLal animals 
le., ., Shope papilloma in rabbits and Moloney 
virua-induced sarcomas in micel and man (e.g., 
aeuroblastoma) undergo spontaneous regression. 
Thia was not due to a lteration of cellui8J· immu-
nity to the tumor cells, since lymphocytes from 
both persistors (in whom tumors were growing) 
llld regressors (in whom the tumors bad re-
cre-dl had the same inhibitory effect on colony 
l'arma.tion. On the oth er hand, incubation of the 
tumor cell cultures with serum from persisters 
abolisbed the tumor-inhibiting effect of both per-
lilt.or and regressor lymphocytes (Fig. 5-9). 
Serum from regressors did not interfere with the 
antitumor activity of these lymphocytes. 
The serum of tumor-bearing individuals has 
afteD been shown to block the activity of tumor-
lplcific immune lymphocytes in the colony-
illbibit.ion technique. This serum blocking activ-
ity has been associated with tumor-specific an-
tibodies or with antig:;m-antibody complexes. Pro-
Penis tor 
LYftlphocytes 
or 
Regresso r 
lymphocytes 
vided that these antibodies or complexes have a 
si milar effect in vivo as in vitro, the presence of 
serum blocking activity would be a powerful 
mechanism of escape from an efficient lympho-
cyte-mediated immune surveillance of tumor 
growth. Ifthe development of blocking antibodies 
plays an important role in enabling tumors to 
g row in an immunologically sensitized host, it 
should be possible to inhibit tumor growth by 
measures that counteract the blocking activity, 
either by the prevention of blocking antibody for-
mation or by intervention with its action. In this 
respect, it was found that in Moloney sarcomas of 
mice and other tumor systems admixture of re-
gressor serum to persister serum abolishes the 
blocking activity of regressor serum, and the 
blocking activity of persister serum is not well 
understood. 
Host-Tumor Relationships and 
/mmunosurve/1/ance 
From a teleologic standpoint, it is generally ac-
cepted that the lymphoid system may have 
evolved in vertebrates for the purpose of seeking 
out, recognizing, and destroying malignantly a l-
Control Cultures 
+8 
Saline 
or 
Normol 
Serum 
+ ~ Persis tor Se rum 
+tj Regressor Serum 
(;) 
~H Colony-inhibition assay. Lymphocytes from hosts with grow1ng tumors (persisters) and from hosts 
... ~tumors (regressors) inhibit the in-vitro formation of tumor colonies. Serum from persistors block 
1101.....,.; biting effect of both persist or and regressor lymphocytes. In contrast, serum from regressors does 
...._ this blocking effect and may even have the capability to "unblock" the blocking act ivity of persister 
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TABLE 5-5 MALIGNANT CONDITIONS IN PATIENTS WITH IMMUNCC ~lENey· 
Number of 
Primary Disease 
Patients Who 
De11e/oped 
Malignant 
Condition 
Types of 
Malignant Conditions 
i' centage 
of tlents 
I• ., Cancer 
Infantile sex-linked 
agammaglobulinemia 
Ataxia-telangiectasia 
Wiskott-Aldrich syndrome 
Common variable immunodeficiency 
Severe combined immunodeficiency 
"Observations by Dr. R. A. Good. 
5 
42 
13 
30+ 
3 
tered tissue. This surveillance system may be just 
another homeostatic control mechanism throug h 
which the host maintains its integrity. Faulty 
immunosurveillance is generally a ssociated wi th 
increased incidence of malignant disease. De-
creased immune function normally presen t in im-
mature or aging animals or experimentally in-
duced by irradiation, neonatal thymectomy, and 
ad.n;Unistration of immunosuppressive drugs or 
antilymphocyte serum is often associated with an 
~creased susceptibility to malignancy. In addi-
tton, m~ch c~icaJ evidence links the lymphoid . 
system mextricably with malignant change in 
man. Regardless of the nature of the disorder :all 
forms of primary immunodeficiency of m an h'ave ~own e~dence of increased susceptibility to ma -~gnant dtSease. For example, patie n ts with a sex-~~ recessive Bruton type agammaglobu-
!femJa are inordinately susceptible to t he e~opment of leukemia. A high incidence of :Ia ~ant ~sease is also found in atax:ia-
ticul Dfl~Ja. These diseases are frequently re-
k ~m ce sarcomas, lymphosarcomas, and le u-
·:188• but epithelial malignant diseases espe-~~ Y 0~ the gastrointe~tinal tract and of other ~rting and m~sencbymal tissu es, have a lso 
droreported, Patients with the Wiskott-Aldrich 8YD me have a hi h fr disease th g equen cy of malignan t ticuJ~ ~ ~ost co~on form of which is a r e-
as well~ ~mo; which .often affects the brain 
organs, A hi h ~ .Ymph01d an~ bema~poiet i c 
encounteredg . lDCldence of malignant disease is 
syndromes (T~le ~~\. other inununodeficiency 
Conversely mal' . 
system such ~ H tgn~~ d1~ase of the lymphoid 
loma, and chro . ~kin s ~1sease, multiple mye-
fest severe rnaffi:c ~mphatic leukemia all mani-
munity, or both ~cti~ndofh_um~ral or cellulaJ· im-
deecnbed in ·. uc ~ficJencies have also been 
patients With malignan t diseases of 
Leukemia 
Many 
MosUy 
lymphoreticular 
Many 
f. I 1 per cenL 
II • • 1 ·, per cenl 
I t per cent 
1 J per cent 
11 per cenL 
non lymphoid organs. Thcs• . wnls respond sub-
normally to immuno~eni,· 1 ulation with teta· 
nus toxoid, dinitrochlm·, •, · ene rDNCBl, and 
tuberculin. For instance 1 1 , mability of breast 
cancer patients to becon••· !ll•n.silized to DNCB 
has been associaled with , ••I' prognosis. It is 
quite likely that the 1m1• 111 defect in these 
cancer patients is a co ).tt-..nce of advanced 
disease and not ils caust 
The concept of immum 1 ullance shoul~ by 
no means be construed , ttu• only mecham~m 
ser ving to control nt>u~ 1 1c change .. For I.D· 
stance, the role of hormot'•· in the survetiJanceof 
e ndocl'ine tissue and t he tumors is well docu· 
mented. Contact inh1b1• nf isolated aberrant 
cells provides anotht 1 n.< chanism. o~ .5~~ 
veillance. Closely r escrnl>hnt t:~nl~ct.J~~J bJII~ . 
is the phenomenon of tllug~·neJc mhlbtti~n, 1j 
which cells with diffcn.'rL :-.1! uctures on the1rce. 
s urfaces mutually in hib:1 lll'll' growth whe~; 
con tact with each other A ,, wly formed neop II> 
tic cell may be elimm .. 1 ·d hv the normal ceh· 
around it long before it IJ, ,·nn es recognized by.t e 
. f th se nonun· tmmune system. The :'\t~l r u1ce? e ainsl 
munologic mechantsm,.. n .;urvedlance ag 
malignancy is difficult I· Jl'scss. . 
58 
pear 
The combined sun·~tll.111n mechamsm / ant 
to be most effective tn tht L'ontrol of ma:Sil-e 
change. In spile of thP eout1nuous and ex. veTY 
exposure to carcinogeni< 1eents, cance~ .'8 \l'e 
· L addJtl0°• uncommon tn most 11g-~ gwups. n type£ 
probably carry oncnJ!Pntt' vt ruses (e.;~plasrns 
RNA virusesl wh1ch m:1~ mduce 
under certain condJlion..;. en illl' 
Although the 3!-'SOciatiOn be~W~dence o[ 
munodeficiency and tht mcreased 10~~ IJ)(JSI 
malignant disease ll' I\'(• II documen ~~ irn· 
cancer patients have nu l11slory of app~n.••n~ 
. . · · these"...,...,... 
munodefic1ency d1sorders. It IS 10 ·c 8beJ11· 
that. the relation lwhwt•n tmmunologt 
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ticJD aud neoplastic growth is poorly understood. 
Severa) mechanisms have been proposed by 
which tumors can overcome immunosurvei I lance 
bJ the lymphoid system. The escape of neoplastic 
powth from immunosurveillance may occur at 
the level ofinduction of the immune response (af-
ferent limb) or at the level of expression of i mmu-
Dity (efferent limb). 
In the afferent limb of the immune response, 
the tumor antigens should be regarded as tumor 
immunogens. The structw·e and physiochemical 
uture of these immunogens , as well as the 
IJIIOUDta present in the tumor and available for 
immunogenic stimulation, obviously have great 
iD8uence on the outcome of the tumor-specific im-
JIIIIIIe response. When a cell undergoes a neo-
plutic: change, it seems quite likely that sufficient 
IIIIOUDta of tumor-specific antigen must be pres-
eat on that cell to stimulate the immune system. 
Tberefore, this neoplastic cell wi!J probably 
have to undergo a number of divisions before 
ldcient quantities of tumor-specific antigens 
are present to eHcit an immune response. 1m-
-.opoic stimulation of the lymphoid system 
il probably induced by the antigenic structures 
}lllll!llt on tumor cell break-down products, 
.ta 18 c:ell membranes, which enter the regional 
I,llpb nodes by way of the draining lymphatics. 
WileD the immunogenicity of the tumor is low, 
•when the tumor has a high cellular prolifera-
tiaa rate, the tumor may outgrow its suscepti-
lilitJ to the effects of the immune svstem and 
.._ -.pe immune surveillan ce. · 
IDaperimental studies, it has been shown that 
llflllareofthe animals to an oncogenic virus or a 
Clft:!Dopn will temporarily suppress the im-
-l'elponse. With reference to the unknown 
llialoo of moat human cancers, it is not known 
wlledaer this potential suppression of the im-::::a l'llponse is relevant to the development of 
malignant disease. ~uaologic factors may suppress lhose cells 
lacr' most surface immunogenici ly and "se-
.. ~-~Hs with the least immunogenidty. 
.. -~lection may represent a mechan-
..!t. ~ch a neoplastic cell with low immUllO-
i;;;";{ meaks tbxougb" the immunosurveil-
'nae the host. 
~ti~ background of the host may also 
....._. his ammune system. It bas been demon-
... ~ the quantity as well as the quality of 
......._ response is controlled by "immune 
..._. ~nes." some of which appear to be as-
~th transplantation genes. Several in-
... ~ewe! have o~rved that these operate at J....a.:.::~ the antagen-reactive thymus-derived 
~but others have indicated that an-
-.....; ng B cells may also be involved. 
.._.. ~that. these genes may be one of 
Jilltic :-rue: factors affecting a variety of neo-
autoaUergic diseases. For instance, 
the resistance of mice to Gross virus leukemo-
genesis is under the influence of two genes, one of 
which is the immune r esponse gene, the other a 
histocompatibility gene. ln this respect it is inter-
esting to note that certain types of malignant 
disease occur in higher frequency in patients hav-
ing specific combinations of transplantation an-
tigens. For instance, the presence of HLA-5 an-
tigen is associated with an increased incidence of 
Hodgkin's disease. 
ll is possible that th e host has developed im-
munologic tolerance to his tumor, similar to the 
chimeric state seen after transplantation of he-
matopoietic and other tissues, so that rejection 
does not occur. Pregnancy represents a compara-
ble balanced immunologic relationship whereby 
the graft, the fetus, survives in an im-
munologically incompatible host, the mother. ln 
chimerism. as in the host-tumor relationship, we 
appear to be dealing with a complex set of biologi-
cal problems involving the potentiality for adap-
tation by the graft or tumor and the host. Our at-
tention in tumor immunology has been focused 
on immunologic adaptation by the host. Atten-
t ion must be given to t.he possible contr·ibution of 
the tumors in this process . 
Even when a host develops a vigorous immune 
response against the tumor, i.e., an effective cel-
lul ar immunity which may be accompanied by 
humoral cytotoxic antibody formation, t he possi-
bility still exists that the tumor survives in the 
host. This situation is prevalenL in many tumor 
systems as demonstrated by the presence of 
blocking factors which interfere with the anti-
tumor activity of tumor-specific immune lympho-
cytes in the colony-inhibition technique. These 
blocking factors resemble the antibody molecules 
responsible for the phenomenon of immune-
enhancement. Experimental studies have shown 
t hat passive transfer of tumor-specific anti-
bodies into a syngeneic host exerts an enhanc-
ing effect on the growth of a transplant of thal 
tumor. Also, mixing of humoral antibody with 
tumor cells in vitro made possible their develop-
m ent into tumors under conditions which other-
wise precluded such events. Several explanations 
have been proposed about. the mechanism of im-
munoenhancement by humoral antibodies. An 
essential component is that such protecti ve ac-
tion by humoral antibodies is likely to take place 
in situations in which the host defense is pri-
marily mediated by immune lymphocytes. One 
explanation is that immunoenhancement is ac-
tive at the efferenL Hmb of lhe immune response . 
T h e antigenic determinants on the tumor cell 
surface are blocked by antibody so that immune 
lymphocytes do not recognize these antigens and 
therefore do not attack tumor cells. T h ese hu-
mor al antibodies may also prevent tumor an-
tigens from sensitizing lymphocytes or they may 
interfere with proliferation or new reactive popu-
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lations of immune lymphocytes. These postulates 
for the mechanism of action of enhancing an-
tibodies may also apply to those factors which 
block the activity of tumor-immune lymphocytes 
in the colony-inhibition assay. However, recent 
evidence seems to indicate that the blocking fac-
tors are circulating complexes between antibody 
and tumor-associated antigens. 
An important consideration should be gi ven to 
.the role of tumor-associated antigens in the ef-
ferent Limb of the host immune response to the 
tumor. They can be classified into two groups: (1) 
those antigens present on the cell surface that 
have been called tumor-rejection antigens, and 
(2 ) the soluble antigens localized in the cell cy-
toplasm and nucleus to which specific immunity 
has little effect on tumor growth. The avallabitity 
of tumor-rejection antigens to the effector mecha-
nisms of humoral and cellular immunity greatly 
influences their efficiency. For instance, tumor 
antigens deeply embedded in the cell surface are 
inaccessible to antibodies as well as to immune 
lymphocytes. Also, the density of tumor-rejection 
antigens on the cell surface is relevant to the ef-
fectiveness of certain types of immune responses. 
For example, IgG complement-fixing antibody 
requires a relatively high density of tumor an-
tigen to induce a cytotoxic effect on the tumor cell 
because of the requirement of the close proximity 
of at least two IgG molecules on the surface to ac-
tivate the complement sequence (see Chapter 4). 
The same cytotoxic complement-fixing antibody 
does not exhibit this effect when the density of 
the tumor-rejection antigen is low. In this situa-
tion, by combining with the antigens on the 
tumor cell, this antibody may interfere with the 
effector mechanisms of tumor-specific cellular im-
munity. 
Clinical Applications of Tumor 
lmmunobio/ogy 
Our rapidly expanding knowledge of tumor im-
munology has provided a basis for the immuno-
logic approach in the diagnosis and treatment of 
malignant disease. Since the demonstration of 
tumor-specific antigens in a great variety of 
human malignant diseases, many attempts are 
underway to isolate and purify these substances. 
The development of practical tests for tumor 
antigen detection should enhance diagnosis and 
permit detection of residual tumor after therapy. 
Tumor-specific immunity, both cell-mediated 
and humoral, can now be assessed in vitro on an 
experimental basis. However , most of the 
methods involved are technically difficult and not 
practical for routine use. 
Evaluation of the general status of the immune 
system of the tumor patient can be of prognostic 
value. For example, total lymphocyte counts are 
low, delayed hypersensitivity reactions to com-
mon antigens are l.ess frequent, ph 1hemagglo· 
tinin-induced transformation of 1) .phocytes is 
reduced, and susceptibility to set• lttzation to 
DNCB is impaired in cancer pali• who have 
extensive and disseminated dif't-' • Unfortu· 
nately, these observations are apph·· ·ble to some 
tumors but not to others. 
Another important application 1 1 tumor im-
munology is the use ofimmunologi. :.rinciples in 
the treatment of cancer. ln most cn.'-· the central 
problem of tumor immunotherap) · not that of 
inducing the patient to become ; r •tune to his 
t umor, but rather to make exis11 immunity 
more effective in controlling tum rrowth. lm· 
munotherapy must attempt to dir"'. the interac-
t ion between tumor growth and l ll• or immunity 
in favor of the host, e ither by qu. tative aug· 
mentation of immunity or by qu. a tive alt.er· 
ation of the immune response so w- l•. expose new 
tumor vulnerabilities. The approae. , of augment· 
ing tumor-specific cell-mediated i ., ,;une mecha· 
nisms or depression of the humor. 1 1mmune re-
sponse should be considered with so~e 
skepticism, since many of thr · nmunolog~c 
aspects of the interaction between ho"'t and tumor 
are still poorly understood. . 
Attempts to increase cell-medt. ·,·d immumty 
by adoptive transfer of allogeneic J ""'. kocytes (rom 
other individuals who had spont.,.,t•ous regres· 
sion or who bad been tumor-immunized has bad 
limited success. This may be a Ll .huted to .the 
relatively short life span of the hi :-.1 1 \ncompattble 
lymphocytes or to a graft-versus-h1 1 reaction .oc· 
curring in patients receiving immP •tnsuppressiOD 
by their tumor or by chernotherap> On the oth~ 
hand, adaptive transfer thrOU J.!H the .use. 
t ransfer factor obtained from tumr•r-spec1fic ~~; 
mune lymphocytes may be a potl'rttially usefw 
approach. . 
Another approach to augment .wm of ac~l'f 
tumor immunity is to increase or ,titer the un· 
munogenicity of tumor cells. For e\.<Unple, tUJllOr 
cells have been altered chemicalh or enz~s­
tically so that they become more immunogelllc. 
Painting of skin sensitizers such a~ ONCB on su· 
perficial squamous ski n cancers of DNCB-se~SI· 
tized patients, has induced selective tumor reJec-
tion. This method represents a new approach 10 
the control of dermal cancers. ·on 
In addition to the specific augmentatt 
methods mentioned above, nonspecific augm~ 
tion of tumor immunity appear~ to have Jini· 
achieved through immunization with BCG. C P" 
cal trials using tbis approach to immunothera · 
of leukemia have been relatively ;;uccessful. ra1 
Finally, cautious manipulation ~f the h~~lll 
immune response of the cancer paltent !e.g., !~­
blocking antibody to unblocking antib<>?Yl or~ 
ministration of unblocking anti botl) wtth tu iJII" 
specificity may offer a promisi ng approach to 
munotherapy. 
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